Theratechnologies Reaches Agreement with AIDS Drug Assistance Program (ADAP) for New Egifta SV™

Sep 19, 2019
PDF Version
Supporting Materials:

Theratechnologies Inc. (TSX: TH) is pleased to announce that an agreement has been reached with the AIDS Drug Assistance Program Crisis Task Force for Egifta SVTM (tesamorelin for injection), which will commercially launch in the United States very shortly.